The Latest In Oxaloacetate Research
NDNR Highlights Oxaloacetate as a Breakthrough ...
We’re excited to share that oxaloacetate and our ongoing work in ME/CFS and Long COVID research were recently featured in NDNR (Naturopathic Doctor News & Review) in an article authored...
NDNR Highlights Oxaloacetate as a Breakthrough ...
We’re excited to share that oxaloacetate and our ongoing work in ME/CFS and Long COVID research were recently featured in NDNR (Naturopathic Doctor News & Review) in an article authored...
Oxaloacetate CFS Earning Widespread Attention F...
After its launch in 2023, Oxaloacetate CFS immediately gained the attention of the ME/CFS research community. Research collaborations with Stanford University, Mount Sinai Health System, The Bateman Horne Center, University...
Oxaloacetate CFS Earning Widespread Attention F...
After its launch in 2023, Oxaloacetate CFS immediately gained the attention of the ME/CFS research community. Research collaborations with Stanford University, Mount Sinai Health System, The Bateman Horne Center, University...
IACFS/ME Lecture On Therapeutic Use of Oxaloace...
Dr. Susan Vernon Discusses Clinical Data of Oxaloacetate Showing Fatigue and Cognitive Function Improvements in ME/CFS and Long COVID patients At the forefront of ME/CFS research, the Bateman Horne Center...
IACFS/ME Lecture On Therapeutic Use of Oxaloace...
Dr. Susan Vernon Discusses Clinical Data of Oxaloacetate Showing Fatigue and Cognitive Function Improvements in ME/CFS and Long COVID patients At the forefront of ME/CFS research, the Bateman Horne Center...
Bateman Horne Center Deepens the Science Behind...
The journey toward effective treatments for Myalgic Encephalomyelitis Chronic Fatigue Syndrome (ME/CFS) and Long COVID has long been hindered by a lack of objective measurement and translational research grounded in...
Bateman Horne Center Deepens the Science Behind...
The journey toward effective treatments for Myalgic Encephalomyelitis Chronic Fatigue Syndrome (ME/CFS) and Long COVID has long been hindered by a lack of objective measurement and translational research grounded in...
Oxaloacetate improves Cognition in ME/CFS and L...
In a newly published article in “Frontiers in Neurology”, a double-blinded, randomized, controlled clinical trial at the Bateman Horne Center, an ME/CFS Center of Excellence, found that a metabolite, “Oxaloacetate,”...
Oxaloacetate improves Cognition in ME/CFS and L...
In a newly published article in “Frontiers in Neurology”, a double-blinded, randomized, controlled clinical trial at the Bateman Horne Center, an ME/CFS Center of Excellence, found that a metabolite, “Oxaloacetate,”...
New Double-Blind Clinical Trial: Oxaloacetate I...
A new randomized, double blind clinical trial peer reviewed and published by Frontiers in Neurology has demonstrated that oxaloacetate significantly improves cognitive function in patients with Myalgic Encephalomyelitis Chronic Fatigue...
New Double-Blind Clinical Trial: Oxaloacetate I...
A new randomized, double blind clinical trial peer reviewed and published by Frontiers in Neurology has demonstrated that oxaloacetate significantly improves cognitive function in patients with Myalgic Encephalomyelitis Chronic Fatigue...